Drug and Alcohol Dependence

Article	Citations
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	291
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	212
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	126
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	119
Editorial Board	96
Editorial Board	89
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	87
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	83
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	78
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	73
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	67
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	64
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	60
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	60
Corrigendum to “Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study” [Drug and Alcohol Dependence 219 (2021) 108435]	59
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	55
Correlates of solitary alcohol and cannabis use among American Indian adolescents	54
The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data	54
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	50
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	49
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	49
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	49
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	48
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	48
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	47

Why do Americans use marijuana?	46
Validation of a single question for the assessment of past three-month alcohol consumption among adolescents	45
Socioeconomic inequalities in alcohol consumption in Argentina: Comparative analysis from 2009, 2013, and 2018	45
Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: A longitudinal analysis	43
Prescription opioid use and employment: A nationwide Finnish register study	42
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis	42
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	41
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	40
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	40
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	39
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	39
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	39
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	39
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	38
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	37
Clinical Translation of the HR/LR Model of SUD Propensity	37
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	37
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	36
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	36
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	35
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	35
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	35
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	35
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	34
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	34
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	34
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	33
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	33
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	33
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	32
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	32
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	32
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	32
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	32
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	32
Preferences for Abstinence-Based Recovery and Public Stigma Toward Substance Use	31
TERPENE AND CANNABINOID PROFILE PREFERENCES AND CANNABIS USE PRACTICES IN MEDICAL CANNABIS PATIENTS WHO USE CANNABIS FOR PAIN AND ANXIETY	31
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	31
More Stress Than You Know: A Qualitative Study of Client Experiences Navigating MOUD Treatment	31
A Pilot Study of 16-Week Intensive Outpatient Treatment for Gay and Bisexual Men With Methamphetamine Use Disorder in Taiwan	31
XYLAZINE: AN ADULTERANT DRUG OF CONCERN	31
Avoidance of Racial Trauma Exposure and Concurrent Substance Use Among Racial/Ethnic Minoritized Young Adults	31
Perceived Stigma on the Emotional Wellbeing Among Latinx With Substance Use Disorders: The Mediated Roles of Self-Stigma and Self-Efficacy	30
How Common is Fentanyl Contamination of Methamphetamine? Attitudes, Self-Reported Exposures, and Toxicology Data From Persons who Use Methamphetamine	30
A Novel 3mg Naloxone Nasal Spray for the Over-the-Counter Market	29
SYMPOSIUM: 10 YEARS GONE: REMEMBERING BILL WOOLVERTON THROUGH HIS IMPACT ON OUR CURRENT RESEARCH PROGRAMS	29
Ethical and Methodological Challenges in Studying Discontinuation of Medications for Opioid Use Disorder	29
Post-Stress Late Positive Potential Prospectively Predicts Cannabis Use Disorder Severity in Cannabis Using Women	29
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	29
A Novel Hand-Held Personalized Dual Biometrically Controlled Device for At-Home Dispensation of Methadone	29

Treatment Engagement, Cigarette Smoking, and Quit Attempts one Month After a Randomized Controlled Trial of E-Cigarette Reduction Among Dual Users	29
Relationship perceptions and conflict behavior among cannabis users	29
Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence	28
The influence of social relationships on substance use behaviors among pregnant women with opioid use disorder	28
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis	27
Health care provider decision-making around prenatal substance use reporting	27
Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997-2017	27
Substance-induced mental disorders and discontinuation of medication for opioid use disorder	27
The centrality of craving in network analysis of five substance use disorders	26
An investigation of multimodal predictors of adolescent alcohol initiation	26
Effects of very low nicotine cigarettes, e-cigarettes, and nicotine patches on daily own-cigarette abstinence in a randomized controlled switching trial	26
Cannabis use and subjective response to alcohol in the human laboratory	26
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	26
Exploring the relationship between sleep disturbances and cannabis use outcomes among Hispanic/Latino young adults	26
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	26
Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State	26
CULTURALLY RESPONSIVE TRAINING TO PRACTITIONERS: REDUCING MENTAL HEALTH DISPARITIES AMONG HISPANIC AND LATINOS	26
How has the brain disease model of addiction contributed to tobacco control?	25
CHARACTERIZING MULTISYSTEM STIGMA: EXAMINING ITS ADVERSE IMPACT ON MOTHERS' ENGAGEMENT AND RETENTION IN RESIDENTIAL SUD TREATMENT	25
Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction	25
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system	25
Protecting historically marginalized groups or targeted marketing? A computational analysis of individuals engaging with public and protected cigar-branded tweets	25
Methodological considerations when assessing symptoms of nicotine dependence by cigarette and e-cigarette use behavior and brand	25
VAGINAL INSTABILITY AND DYSBIOSIS IS PREVALENT AMONG HISPANIC WOMEN LIVING IN PUERTO RICO REGARDLESS OF BODY MASS INDEX	25
RECENT INCARCERATION, SUBSTANCE USE, OVERDOSE, AND TREATMENT AMONG RURAL PEOPLE WHO USE DRUGS	24
Rates of Medication Prescription, Mental Health Disorder, and HCV Diagnoses Among Patients With Comorbid Alcohol and Opioid Use Disorder in Rural Primary Care Clinics	24
Modifications to the HEALing Communities Study in response to COVID-19 related disruptions	24
GABAPENTIN UTILIZATION AMONG BUPRENORPHINE-PRESCRIBED INDIVIDUALS WITH OPIOID USE DISORDER AND ASSOCIATED RISK OF OVERDOSE	24
NIAAA Update Presented by George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism	24
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems	24
THE FAMILIAR TASTE OF POISON: A QUALITATIVE STUDY OF MULTI-LEVEL MOTIVATIONS FOR STIMULANT USE IN SEXUAL MINORITY MEN LIVING IN SOUTH FLORIDA	24
Characterizing Empirically-Derived Sub-Groups of Latinx PWID Living Along the U.S.-Mexico Border for HIV and HCV Prevention	24
Domestic Cannabis Cultivation: Results of the Georgian (country) Sample of the Transnational Online Survey of Cannabis Growers	23
Perceptions of Racism’s Impact on Drug Use Among African Americans Using Opioids	23
Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial	23
Factors Associated With Risk for Cannabis Use Disorder Among Adults Using Medical Marijuana in Florida	23
SUVOREXANT, AN FDA-APPROVED DUAL OREXIN RECEPTOR ANTAGONIST, EFFECTIVELY REDUCES OXYCODONE SELF-ADMINISTRATION AND CONDITIONED REINSTATEMENT IN MALE AND FEMALE RATS	23
Substance Co-Exposure Among Women With Opioid Use During Pregnancy	23
Common and Distinct Associations Between Baseline Impulsivity and Longitudinal Development of Positive and Negative Alcohol Expectancies in the Adolescent Brain Cognitive Development (ABCD) Cohort	23
DEPRESSION SCREENING AMONG PERINATAL PATIENTS WITH AND WITHOUT SUBSTANCE USE DISORDERS FOLLOWING IMPLEMENTATION OF A COLLABORATIVE CARE PROGRAM	23
Syndemic Profiles and Opioid-Related Mortality Among People Initiating Chronic Episodes of Prescription Opioid Use in BC, Canada	23
Primary Form of Cannabis Use and Recent Negative Affect Symptoms	23
Brandeis/Harvard Spire Center: SUD Systems Performance Improvement Research and Engagement	23
Sex Differences in the Prospective Association of Intra-Individual Reaction Time Variability in Stroop and Hazardous Cannabis Use at Six Months	22
Cannabis Use Effects on Reaction Time in Daily Versus Occasional Users	22
Self-Perception of Smoking Status and Co-Use of Cannabis and Narcotic Pain Medication	22
Performance of a Brief Substance Use Symptom Checklist (SUSC) for Identifying Substance Use Disorder Among Primary Care Patients With or at Elevated Risk for Opioid Use Disorder	22
Disparities in the Hepatitis C Virus Cascade of Care Among Reproductive Age Women With Opioid Use Disorder	22
Behavioral and Psychosocial Predictors of Cannabis Use Among Youth During the COVID-19 Pandemic	22
Psychosocial and Drug Use Characteristics in Persons With Opioid Use Disorder and Chronic Pain	22
Characterization of Peer Support Services for Substance Use Disorders in 11 U.S. Emergency Departments in 2020: Findings From a Nida Clinical Trials Network Study Site Selection Process	22
Outcomes of the Community-Based Medication-First Program for Opioid Use Disorder: A Multisite Hybrid Implementation Study	22
Treatment Outcomes From Computerized CBT for Substance Use Disorders Among People With Criminal Justice Involvement	21
Prospective association between screen use modalities and substance use experimentation in early adolescents	21
Latent profiles of impulsivity facets and associations with drinking behaviors	21
Modeling cue-exposure therapy for alcohol use disorder in rhesus monkeys: Effects of putative cognitive enhancers	21
MEDIA FORUM	21
Adolescent depression symptoms and e-cigarette progression	21
Trends in poisonings involving ketamine in the United States, 2019–2023	21
Editorial Board	21
Optimizing Recovery Funding: Barriers to Acquiring Funding Among Organizations in the Ecosystem of Recovery	21
Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies	21
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns	21
Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications	21
Assessing inequities in buprenorphine treatment across the care cascade	21
A Randomized Controlled Six-Way Crossover Study to Characterize the Nicotine Pharmacokinetics of a Novel Oral Nicotine Pouch Product	20
Examining the effect of prescription drug monitoring program integration and mandatory use policies on the distribution of methadone and buprenorphine for opioid use disorder, United States, 2009–2021	20
Naloxone Stigma Among People With Substance Use Disorder: Characteristics and Associations With Stigma toward Medication for Opioid Use Disorder (MOUD)	20
Beyond Euphoria: Transcriptomic Investigation in the rat Brain Under the Administration of Fentanyl Combined With Xylazine	20
Mental Health Care Barriers for Women Involved in the Criminal Legal System With Substance Use Disorders: A Qualitative Study	20
Pregnenolone Effects on Cocaine Use in Individuals with Cocaine Use Disorder	20
Modes of Cannabis Administration and Their Associations With Binge Drinking Among 12th Grade Students in the United States: A Cross-Sectional Analysis from 2018-2021	20
Oral Oxycodone Self Administration in Rats With a History of Responding under a Multiple Schedule for Ethanol and Food or Oxycodone and Food	20
Methodology for Single- vs Polydrug Classification of Poisoning Deaths	20
APP-BASED CONTINGENCY MANAGEMENT TO REDUCE HEAVY DRINKING DAYS AMONG SMOKERS RECEIVING VARENICLINE: FINDINGS FROM A WITHIN-SUBJECT A-B-A DESIGN TRIAL	20
The Association Between Sleep Health and Multiple Tobacco Product Use Among Low-Income Smokers	20
Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse	20
SUBSTANCE USE DISORDERS AND ASSOCIATED MEDICAL CONSEQUENCES: IMPLICATIONS FOR PREVENTION AND TREATMENT	20
Perceptions of the Combining HIV Services and Microenterprise for Sustainable Recovery (CHIMES) Intervention for Sober House Residents in Tanzania: A Qualitative Study	20
Pregnancy Rates Among Women Treated With Medication for Opioid Use Disorder	20

Barriers and Facilitators to Injectable Opioid Agonist Treatment Engagement: A Qualitative Study of Patient Experiences in Vancouver, Canada	20
Differences in Methamphetamine Use and Self-Reported Impact by Gender and Sexual Orientation in a Multisite U.s. Cohort of People with Hiv in Care	20
Sex Differences in Lifetime Non-Medical Prescription Opioid and Cannabis Use Among Older Adults in the All of Us Research Program	20
Causally Linkage of Adolescent Behavioral Anomalies to Prenatal Opioid Exposure	20
Qualitative Exploration of Opioid Overdose Response Steps Among Women Who Use Drugs on the Rural Eastern Shore of Maryland	19
Perceptions of Cannabis and its Associations With Mental Health Amongst Budtenders in Southern Ontario	19
“Icy” Flavor Components in E-cigarette Images: Influence on Liking and Intention to Use Among Youth Who are Susceptible to E-cigarette Use	19
Associations Between Interoceptive Control of Avoidance and Patterns of Morphine Self-Administration	19
Characterizing Online Questions and Answers about Cannabis Use and Pregnancy: Data Mining and Content Analysis on the Social Media Platform Quora	19
Within-Subject Evaluation of Technology-Assisted Buprenorphine Treatment	19
Why Do Medical Cannabis Patients use Illicit Medicinal Cannabis in the State of Utah?	19
Provision of Recovery Support Services in Opioid Use Disorder (OUD) Treatment Settings: A Secondary Data Analysis of the National Survey of Substance Abuse Treatment Services (N-SSATS) Data	19
Impact of the Sudden Closure of Mexico’s Only Methadone Manufacturing Plant on the Mental, Financial and Social Health of Patients With Opioid Use Disorder (OUD) in Tijuana, Mexico	19
A Qualitative Analysis of Individual, Relationship, and Community Factors Influencing Non-Initiation of Medications for Opioid Use Disorder During Incarceration	19
Experiential Smoking Urges and Nicotine Withdrawal Reduction Among People Under Community Corrections Supervision Enrolled in In Vivo NRT Counseling	19
Trends in overdose deaths involving gabapentinoids and Z-drugs in the United States	18
Prevalence and socio-structural determinants of tobacco exposure in young women: Data from the Healthy Trajectories Initiative (HeLTI) study in urban Soweto, South Africa	18
“I Feel like People Would Look at Me like I’m Dirty or like I’m a Thief:” a Qualitative Exploration of Internal Experiences that Influence Recovery Among Adults at Risk of Opioid-Related Overdose	18
In Vivo Imaging Evidence of a Neuroinflammatory Phenotype Among Patients With Opioid Use Disorder	18
Depression Outcomes Among Women Participating in Worth Transitions	18
Structural indices of brain aging in methamphetamine use disorder	18
Editorial Board	18
Assessment of substance exposures in nail clipping samples: A systematic review	18
Racialized Differences in the Prevalence of Drug Use Disorder Among Transgender Veterans	18
Pharmacist Involvement in Motivational Interviewing Intervention for Patients with Prescription Opioid Misuse Behaviors	18
Maryland Opioid Overdose Deaths From 2018 to 2021: Occupational Pattern and Its Sociodemographic Variations	18
Editorial Board	18
Associations between cannabis use, opioid misuse and severe psychological distress in adolescents: A cross-sectional school-based study	18
Conducting Community-Based Research on Substance Use in Rural Canada: Ethical and Methodological Considerations for Future Research	18
Liver Disease Among People who Inject drugs: A Prospective Longitudinal Cohort Study Linked to Administrative Hospital Data	18
Who Gets Treatment And Who Gets Criminalized Racialized Associations Between Cannabis Arrests And Criminal Legal System Referrals To Cannabis Treatment, 1992-2019	18
Prenatal alcohol exposure and offspring subsequent alcohol use: A systematic review	18
Deficits in consummatory reward relate to severity of cocaine use	17
College-based social and situational predictors of real-time prescription drug misuse in daily life	17
Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report	17
Legality of drug checking equipment in the United States: A systematic legal analysis	17
State marijuana policies and vaping associated lung injuries in the US	17
Impact of reduced nicotine content on behavioral economic measures of cigarette reinforcement in adolescents who smoke cigarettes	17
Alcohol use in firefighters: A network model of behaviors and transdiagnostic risk	17
Secondhand electronic cigarette aerosol in vehicles impacts indoor air quality	17
The defining characteristic of substance use disorders	17
Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: A three-arm randomized controlled trial	17
Violence, policing, and systemic racism as structural barriers to substance use treatment amongst women sex workers who use drugs: Findings of a community-based cohort in Vancouver, Canada (2010–2019)	17
Associations of sex-related steroid hormones and proteins with alcohol dependence: A United Kingdom Biobank study	17
Incentivized Collaborative Care to Disseminate Contingency Management via Buprenorphine Treatment	16
Trends of Prenatal Substance Exposure: A 10 Year Evaluation of Umbilical Cord Test Outcomes	16
CAREGIVING AND COPING: ALCOHOL USE DURING THE PANDEMIC IN NEW YORK CITY	16
Positive Methamphetamine Urinalysis Result During Treatment Intake is Not Associated With Worst Treatment Outcomes Amongst Opioid Users Initiating Medication-Assisted Opioid Treatment in Rural Communi	16
“I still partly think this is bullshit”: A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting	16
WORKSHOP: NEW APPROACHES TO CULTURALLY APPROPRIATE TREATMENT AND RESEARCH	16
Health Justice Coordination for Increased Access to Health and Social Services for People With Drug Use Disorders in Contact With the Criminal Justice System	16
Untargeted Umbilical Cord Testing to Detect Novel Psychoactive Substances	16
Gender Differences in Smoking Dependence Motives	16
Oud Treatment, Harm Reduction Service Engagement, and Sexually Transmitted Infection Risk Among Men and Women who Use Illicit Opioids in New York City	16
Emotion Dysregulation Fully Mediates the Relationship between Stress and Impulsivity in Inpatients With Co-Occurring Substance Use and Mental Health Disorders	16
Changes in Opioid Agonist Treatment Initiation Following Voluntary and Mandatory Prescription Drug Monitoring Program Implementation: A Time Series Analysis	16
Exploring Long-Term Trajectories of Quality of Life for People who are Treated With Methadone	16
Drug Decriminalization in the United States: Emerging Models, Implementation Experiences and Implications for Health and Racial Equity	16
Small Business Program: Implementation of a Technological Solution to Support Treatment for Opioid Use Disorder in the Primary Care Setting	16
Access to Medications for Opioid Use Disorders: A Multi-Site Comparison of Qualitative Evidence With Stakeholders	16
Perceptions of Overdose Response Hotlines Among a Sample of People in Treatment for Substance Use Disorder	16
High Threshold Prescribing Practices Associated With Increased Termination of Care: Results From a Survey of Michigan Buprenorphine Prescribers	16
Editorial Board	16
Using Biomarker Ratios to Distinguish Between Exclusive and Dual Use of Cigarettes, Smokeless Tobacco, and e-Cigarettes	16
U.S. older adults’ heroin and psychostimulant use treatment admissions, 2012–2019: Sociodemographic and clinical characteristics	15
A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis	15
Sucrose subjective response and eating behaviors among individuals with opioid use disorder	15
Prenatal Tobacco Exposure and the Risk of Tobacco Smoking and Dependence in Offspring: a Systematic Review and Meta-Analysis	15
Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity	15
Erratum to “Sex differences in circulating inflammatory mediators as a function of substance use disorder” [Drug Alcohol Depend. 221 (2021) 108610]	15
Using community engagement to implement evidence-based practices for opioid use disorder: A data-driven paradigm & systems science approach	15
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats	15
Trends in fatal and nonfatal overdose by race among people who inject drugs in Baltimore, Maryland from 1998 to 2019	15
Hours high as a proxy for marijuana use quantity in intensive longitudinal designs	15
Tobacco and marijuana co-use in a cohort of young adults: Patterns, correlates and reasons for co-use	15
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency	15
A national study on pregaming motives, frequency, consumption, and negative alcohol consequences among university students in the United States	15
The association between community social vulnerability and prescription opioid availability with individual opioid overdose	15
Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai’i who use cannabis: A matched cohort study	15
Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020	15
Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020	15
Perceived racial and social class discrimination and cannabis involvement among Black youth and young adults	15
Editorial Board	15
Older Adults in Opioid Use Disorder Treatment: A Systematic Review of Health Outcomes	14
FcGBP and VCAM-1 are ponderable biomarkers for differential diagnosis of alcoholic liver cirrhosis	14
A Passive Addiction Recruitment Strategy Among HIV Patients in Alabama: An Opportunity for Equitable Research Participation	14
Do Dual Users Vape When Attempting to Quit Smoking? The Association Between E-Cigarette Use and Concurrent Cigarette Cessation-Related Outcomes in a Prospective Natural History Study	14
Blunt and non-blunt cannabis use associated with cigarette, e-cigarette, and cigar initiation: Findings from the population assessment of tobacco and health (PATH) study	14
Comparative Effectiveness of Telemedicine Versus In-Person Buprenorphine Prescribing for Rural and Urban Patients	14
Alcohol-Focused Treatment With Mindfulness-Oriented Recovery Enhancement Shows Additional Beneficial Effects on Craving for Other Drugs	14
A Survey of Chronic Pain Patients regarding Drug Use and Opinions on Brain Stimulation as Treatment	14
Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study	14
SBIR: RAE cHealth: Assessing the Usability and Acceptability of Digital Health Intervention to Support Peer Recovery-Based SUD Treatment	14
Effects of the Social Cold Pressor Task on Stress Reactivity and Alcohol Craving and Demand	14
NEUROLOGICAL AND BEHAVIORAL CHANGES 6 MONTHS AFTER GASTRIC SLEEVE METABOLIC SURGERY	14